Skip to main content
. 2016 Nov 22;8(3):3854–3869. doi: 10.18632/oncotarget.12924

Figure 4. A. Tet-21/N cells were treated with SP2509 or vehicle, fixed and processed for anti-β-catenin immunofluorescence and DAPI staining.

Figure 4

B. Western blot assay of protein extracts of Tet-21/N and SH-SY5Y cells treated as indicated using β-catenin and Cyclin D1 antibodies. α-tubulin has been probed as loading control. *, P < 0,01.